about
Idiopathic noncirrhotic portal hypertension: current perspectivesRole of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infectionHepatitis C in the Russian Federation: challenges and future directionsParitaprevir/ritonavir-ombitasvir and dasabuvir, the 3D regimen for the treatment of chronic hepatitis C virus infection: a concise reviewThe pathophysiology of thrombocytopenia in chronic liver diseaseDaclatasvir-sofosbuvir combination therapy with or without ribavirin for hepatitis C virus infection: from the clinical trials to real lifeAutophagy: a new target for nonalcoholic fatty liver disease therapyChallenging hepatitis C-infected liver transplant patientsAutophagy in hepatocellular carcinomas: from pathophysiology to therapeutic responseManagement options in decompensated cirrhosisLifestyle interventions for the treatment of non-alcoholic fatty liver diseaseDefibrotide in the treatment of hepatic veno-occlusive diseaseObeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selectionInterferon-free combination therapies for the treatment of hepatitis C: current insightsAcute hepatic failure in pediatric H1N1 infection: a case report from Al-Adan Hospital, KuwaitPharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agentsMetabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?Transient elastography with the XL probe rapidly identifies patients with nonhepatic ascitesLiver stiffness: a novel parameter for the diagnosis of liver disease.The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectivesHepatitis C in Argentina: epidemiology and treatment.Hepatitis C infection in Egypt: prevalence, impact and management strategies.Transmission, diagnosis, and management of hepatitis E: an updateRole of intrafamilial transmission in high prevalence of hepatitis C virus in Egypt.Ending hepatitis C in the United States: the role of screening.Cyclic AMP-guanine exchange factor activation inhibits JNK-dependent lipopolysaccharide-induced apoptosis in rat hepatocytes.Surgical treatment of nonalcoholic fatty liver disease in severely obese patientsAnti-Inflammatory Action of Insulin via Induction of Gadd45-β Transcription by the mTOR Signaling Pathway.Potential treatment options and future research to increase hepatitis C virus treatment response rateInsulin-like growth factor binding protein-3 is required for the regulation of rat oval cell proliferation and differentiation in the 2AAF/PHX model.Inhibition of Notch signaling affects hepatic oval cell response in rat model of 2AAF-PH.Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis.Should NS5A inhibitors serve as the scaffold for all-oral anti-HCV combination therapies?Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients.Tyrosine levels are associated with insulin resistance in patients with nonalcoholic fatty liver disease.Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs.Association of cytokine gene polymorphisms with hepatitis C virus infection in a population from Rio de Janeiro, Brazil.Hypothesis: Targeted Ikkβ deletion upregulates MIF signaling responsiveness and MHC class II expression in mouse hepatocytes.A meta-analysis that compares the use of either peginterferon-α2a or peginterferon-α2b plus ribavirin for HCV infection.
P1433
Q26739547-F484A5D5-04E4-4CAA-8203-9D0B9D8DBC3CQ26740216-9C9CF6EC-0921-4B38-B9E5-AB4700672309Q26746198-D2E35632-29F1-4F82-B015-A2306EDFA144Q26747705-C081E50F-F78D-4F2A-9280-4099C65E4C37Q26749277-10CCA736-1F0B-404F-BD7A-2533463880C5Q26750628-C3C2902C-EF67-4B53-9FCA-3073BD96CCD0Q26751326-9EC1977C-F1FD-4BC7-B52A-3A2AAAFFFDD0Q26765020-B806E87B-F6D1-4526-9A00-E787D4E4F8B1Q26767245-64FCD3A8-CCEA-4AF3-AE9C-8FEF18C9BEDEQ26800238-9DC77A9C-6921-4794-96FE-8A419345D793Q26862945-A416737C-5BA6-4223-887D-B091CC11F651Q28068332-024BDCBF-7779-4366-B4A1-7D280A2D6E67Q28072209-343B043C-9311-4123-ADF3-B6C3188F1FF3Q28087400-569009BD-4EA8-415D-B898-6D074B47664AQ30357200-2EDA96AD-741B-4BEC-B07C-9292D95158E2Q30365599-E790A21A-69CA-4CD0-97E0-C8A41549E676Q30369757-3CB9D283-6EB5-489B-A42D-4A84707C2459Q30445525-1F48827D-8FA6-483A-8B1C-DC85E881B9C3Q30445527-5D18F581-A873-40A0-8A38-BAC1A0C3AD9AQ33414386-F0E7FE5C-0D28-4F77-92F7-581341B8FADEQ33568568-E0A92622-2215-4177-BE89-89023E6ECAC6Q33706886-66D68650-8458-4585-AE5D-8BF0ABAD5F55Q33713718-80E24269-14A0-4FF7-9264-641EEAD6E38DQ33734018-C0D19D4E-6E63-4E70-8A99-3EACCD81CC06Q33812849-27B508E8-5CF9-438B-8CB6-6678D1A0CF6DQ33862919-4CAF7835-B91B-4B20-80DC-352CEDD76B71Q33956944-8C3410C1-63BA-4723-BBFE-FF319571C7A5Q34446294-80B8A7C5-D8CC-4CB3-82A5-2175A06E45F2Q34535791-CEA9E6C9-EAE8-4479-A978-67F618E80246Q34576190-D966DE6D-4B6C-488D-BFC0-B374C9DDCDAEQ35165646-B7A46C84-B75C-4AFA-A8FF-5E41F215B7BFQ35212426-D265B384-11F1-4CFE-A4FB-A057440BD4FBQ35226097-F3575B4A-A3BF-4E7C-A97F-D6CF5E387408Q35491398-23CF4D84-8649-4B44-B7E5-648677A90541Q35654638-9E228B1C-CE1E-46E1-A8D5-6DC9776024D3Q35703747-54FD270D-BBF5-4B79-81BE-A6C18FFE2086Q35862181-62FF565A-F2E2-4DB8-98A3-3CC22E4E5BC9Q36257252-1CC24354-09BB-45B9-A4F2-A96A7EF3A2A0Q37131434-A5029393-D1FA-4FDB-994F-66A7198C6A03Q37355366-6682C563-8EE6-4559-B0E2-9E47A706D886
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Dove Medical Press
@nl
wissenschaftliche Fachzeitschrift
@de
name
Hepatic Medicine: Evidence and Research
@ast
Hepatic Medicine: Evidence and Research
@en
Hepatic Medicine: Evidence and Research
@es
Hepatic Medicine: Evidence and Research
@it
Hepatic Medicine: Evidence and Research
@nl
type
label
Hepatic Medicine: Evidence and Research
@ast
Hepatic Medicine: Evidence and Research
@en
Hepatic Medicine: Evidence and Research
@es
Hepatic Medicine: Evidence and Research
@it
Hepatic Medicine: Evidence and Research
@nl
altLabel
Hepatic Medicine : Evidence & Research
@en
Hepatic Medicine : Evidence and Research
@en
prefLabel
Hepatic Medicine: Evidence and Research
@ast
Hepatic Medicine: Evidence and Research
@en
Hepatic Medicine: Evidence and Research
@es
Hepatic Medicine: Evidence and Research
@it
Hepatic Medicine: Evidence and Research
@nl
P31
P3181
P1055
P1058
P1156
21100854853
P1476
Hepatic Medicine: Evidence and Research
@en